Roberto Bellini - 21 Oct 2024 Form 4 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role
Director
Signature
/s/ Roberto Bellini
Issuer symbol
IKT
Transactions as of
21 Oct 2024
Net transactions value
+$2,000,200
Form type
4
Filing time
23 Oct 2024, 19:53:27 UTC
Next filing
19 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IKT Common Stock Purchase $2,000,200 +1,460,000 $1.37 1,460,000 21 Oct 2024 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKT Stock Option (right to buy) Award $0 +60,000 $0.000000 60,000 21 Oct 2024 Common Stock 60,000 $2.22 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are owned directly by BSQUARED CAPITAL INC ("BSQ"). Mr. Bellini is a shareholder and officer of BSQ. Mr. Bellini expressly disclaims beneficial ownership of the securities listed above except to the extent of any pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F2 The option shares vest 50% on each of the first two anniversaries of October 21, 2024.